酵素結合免疫吸着測定法市場規模、シェア、成長分析、製品タイプ別、用途別、技術別、エンドユーザー別、地域別-2025～2032年産業予測

酵素結合免疫吸着測定法の世界市場規模は2023年に24億米ドルと評価され、予測期間（2025～2032年）のCAGRは5.1%で、2024年の25億米ドルから2032年には35億米ドルに成長する展望です。

世界の酵素結合免疫吸着測定法（ELISA）市場は、慢性疾患や感染症の蔓延、アッセイ技術の進歩、創薬や食品安全における幅広い用途によって大きな成長を遂げています。ELISAは抗原や抗体を正確に定量できるため、予防に重点を置いた進化するヘルスケアにおいて、タイムリーな診断や介入を可能にする魅力があります。さらに、ワクチン開発と品質管理における重要な役割は、製薬企業の間でその関連性を高めています。市場はまた、診断精度と検査室の効率を向上させる人工知能、機械学習、IoTの統合による変革期を迎えています。これらの技術により、ELISAは進化する診断環境において不可欠な最先端ツールであり続け、信頼性の高い結果を求める需要の高まりに応えています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 一次と二次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要市場の考察

• 重要成功要因
• 競合の程度
• 主要投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 使用事例

酵素結合免疫吸着測定法市場規模：製品タイプ別&CAGR（2025～2032年）

• 市場概要
• キット
• 試薬
• 機器

酵素結合免疫吸着測定法市場規模：用途別&CAGR（2025～2032年）

• 市場概要
• 臨床診断
• 研究
• 獣医
• その他

酵素結合免疫吸着測定法市場規模：技術別&CAGR（2025～2032年）

• 市場概要
• サンドイッチELISA
• 間接ELISA
• 競合ELISA
• 直接ELISA

酵素結合免疫吸着測定法市場規模：エンドユーザー別&CAGR（2025～2032年）

• 市場概要
• 病院
• 診断ラボ
• 研究機関
• その他

酵素結合免疫吸着測定法市場規模&CAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主要市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

    主要企業プロファイル

    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer, Inc.
    • Merck KGaA
    • Danaher Corporation
    • Abcam plc
    • Becton, Dickinson and Company
    • Agilent Technologies, Inc.
    • R&D Systems, Inc.
    • Enzo Life Sciences, Inc.
    • Ortho Clinical Diagnostics
    • BioLegend, Inc.
    • RayBIoTech, Inc.
    • QIAGEN N.V.
    • GenScript BIoTech Corporation

結論と提言

Global Enzyme-Linked Immunosorbent Assay Market size was valued at USD 2.4 Billion in 2023 and is poised to grow from 2.5 USD Billion in 2024 to USD 3.5 Billion by 2032, growing at a CAGR of 5.1% in the forecast period (2025-2032).

The global enzyme-linked immunosorbent assay (ELISA) market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases, advancements in assay technologies, and a broader range of applications in drug discovery and food safety. ELISA's precision in quantifying antigens and antibodies enhances its appeal for timely diagnosis and intervention in an evolving healthcare landscape focusing on prevention. Furthermore, its vital role in vaccine development and quality control bolsters its relevance among pharmaceutical organizations. The market is also undergoing transformation through the integration of artificial intelligence, machine learning, and IoT, which improve diagnostic accuracy and laboratory efficiency. These technologies ensure ELISA remains an indispensable, cutting-edge tool in the evolving diagnostic landscape, catering to rising demand for reliable results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enzyme-Linked Immunosorbent Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enzyme-Linked Immunosorbent Assay Market Segments Analysis

The global enzyme-linked immunosorbent assay market is segmented into product type, applications, technology, end users, and region. By product type, the market is categorized into kits, reagents, and instruments. Depending on application, it is classified into clinical diagnostics, research, veterinary, and others. Based on technology, it is divided into sandwich ELISA, indirect ELISA, competitive ELISA, and direct ELISA. Based on end user, it is categorized into hospitals, diagnostic laboratories, research institutes, and others. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver of the Global Enzyme-Linked Immunosorbent Assay Market

A key market driver for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Market is the increasing prevalence of chronic diseases and the rising demand for accurate diagnostic tools. As healthcare systems worldwide strive for improved disease management and early detection, ELISA techniques are gaining prominence due to their sensitivity, specificity, and versatility in detecting a range of biomarkers. This trend is further amplified by advancements in biotechnology and pharmaceuticals, which are driving research and development of novel assays. Additionally, the growing emphasis on personalized medicine and preventive healthcare is propelling the demand for ELISA tests in clinical and research settings.

Restraints in the Global Enzyme-Linked Immunosorbent Assay Market

One of the key market restraints for the global enzyme-linked immunosorbent assay (ELISA) market is the high cost associated with advanced ELISA diagnostic kits and necessary laboratory equipment. These expenses can limit accessibility for smaller laboratories and healthcare facilities, especially in developing regions where budget constraints are more pronounced. Additionally, the complexity of ELISA procedures may require specialized training for personnel, further compounding costs and contributing to the potential inefficiencies in workflow. As a result, these financial and logistical challenges may hinder the widespread adoption of ELISA technologies, impacting market growth and innovation.

Market Trends of the Global Enzyme-Linked Immunosorbent Assay Market

The Global Enzyme-Linked Immunosorbent Assay (ELISA) market is witnessing a significant trend towards the adoption of automated and high-throughput platforms. Laboratories and diagnostic centers are increasingly integrating advanced automated ELISA analyzers, which enhance efficiency by automating processes such as plate loading, reagent dispensing, and result reporting. This automation mitigates human error and accelerates turnaround times, making it particularly advantageous in high-demand contexts like pharmaceutical research and vaccine development, where processing large volumes of samples swiftly is essential. This shift towards automation is poised to transform ELISA applications, contributing to improved diagnostics and research outcomes across various sectors.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Enzyme-Linked Immunosorbent Assay Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Kits
• Reagents
• Instruments

Global Enzyme-Linked Immunosorbent Assay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Diagnostics
• Research
• Veterinary
• Others

Global Enzyme-Linked Immunosorbent Assay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sandwich ELISA
• Indirect ELISA
• Competitive ELISA
• Direct ELISA

Global Enzyme-Linked Immunosorbent Assay Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

Global Enzyme-Linked Immunosorbent Assay Market Size & CAGR (2025-2032)

• North America (Product Type, Application, Technology, End User)
  • US
  • Canada
• Europe (Product Type, Application, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R&D Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Life Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations